NEW YORK--(BUSINESS WIRE)--Serial Biotech Entrepreneur, Cathy Tie, today announced the launch of Origin Genomics, a New York–based company dedicated to advancing precision germline gene correction for severe inherited diseases. The company launch follows the constructive conclusion of Manhattan Genomics. Cathy Tie is now launching the next chapter of her work, continuing to advance responsible genomic medicine. Origin Genomics will operate exclusively in the United States, with research conduct
2026 Copyright © News-Matic.com. All Rights Reserved
